THOMAS H. MCLAIN - 10 Jul 2023 Form 4 Insider Report for Renalytix plc (RNLX)

Role
President
Signature
/s/ Katie Kazem, Attorney-in-Fact
Issuer symbol
RNLX
Transactions as of
10 Jul 2023
Transactions value $
$0
Form type
4
Filing time
11 Jul 2023, 16:49:15 UTC
Previous filing
07 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNLX Employee Stock Option (right to buy) Award $0 +200,000 $0.000000 200,000 10 Jul 2023 Ordinary Shares 200,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price is 1.175 pounds sterling. The U.S. dollar equivalent of the exercise price is $1.506 using the Bank of England rate as of July 10, 2023 (1.00 pound sterling = $1.282).
F2 One twelfth (1/12th) of the shares subject to the option award shall vest in equal quarterly installments commencing on October 10, 2023, subject to the Reporting Person's continuous service.